These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6149951)
1. [Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats]. Kharlamov AN; Shumkova OV; Blinkova NF; Tolmacheva NS; Raevskiĭ KS Farmakol Toksikol; 1984; 47(5):11-5. PubMed ID: 6149951 [TBL] [Abstract][Full Text] [Related]
2. [Effect of sodium valproate on the mediator amino acid content in the rat brain]. Kharlamov AN; Kovalev GI; Shumkova OV Farmakol Toksikol; 1982; 45(5):31-4. PubMed ID: 6128253 [TBL] [Abstract][Full Text] [Related]
3. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice. Luszczki JJ; Mohamed M; Czuczwar SJ Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497 [TBL] [Abstract][Full Text] [Related]
4. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model. Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590 [TBL] [Abstract][Full Text] [Related]
5. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. Bell EC; Willson MC; Wilman AH; Dave S; Asghar SJ; Silverstone PH Hum Psychopharmacol; 2005 Mar; 20(2):87-96. PubMed ID: 15651051 [TBL] [Abstract][Full Text] [Related]
6. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? Lenox RH; McNamara RK; Watterson JM; Watson DG J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502 [TBL] [Abstract][Full Text] [Related]
7. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Swiader M; Wielosz M; Czuczwar SJ Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441 [TBL] [Abstract][Full Text] [Related]
8. Valproate and myoclonus. Chapman AG Adv Neurol; 1986; 43():661-74. PubMed ID: 3080855 [TBL] [Abstract][Full Text] [Related]
9. Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. Willson MC; Bell EC; Dave S; Asghar SJ; McGrath BM; Silverstone PH Eur Neuropsychopharmacol; 2005 Dec; 15(6):633-9. PubMed ID: 15949922 [TBL] [Abstract][Full Text] [Related]
10. Effect of antiepileptic drugs on the cerebral amino acid uptake in vitro. Saladini M; Gabana MA; Bracco F; Zanchin G; Maggioni F; Battistin L Ital J Neurol Sci; 1981 Dec; 2(4):351-60. PubMed ID: 6120919 [TBL] [Abstract][Full Text] [Related]
11. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain. Bolaños JP; Medina JM Mol Pharmacol; 1993 Mar; 43(3):487-90. PubMed ID: 8450838 [TBL] [Abstract][Full Text] [Related]
12. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice. Umeda K; Suemaru K; Todo N; Egashira N; Mishima K; Iwasaki K; Fujiwara M; Araki H Eur J Pharmacol; 2006 Dec; 553(1-3):157-62. PubMed ID: 17070517 [TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant activity of 4,9-dioxo-5,10-diazatetradecane (CM 40142), a new GABA derivative, in mice and photosensitive baboons). Chambon JP; Molimard JC; Calassi R; Maruani J; Rodier D; Sigault G; Leyris R; Roncucci R; Bizière K Arzneimittelforschung; 1984; 34(9):1017-21. PubMed ID: 6439227 [TBL] [Abstract][Full Text] [Related]
14. Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals. Morland C; Nordengen K; Gundersen V Neurosci Lett; 2012 Oct; 527(2):100-4. PubMed ID: 22963924 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of chronic lithium and valproate on brain activation in healthy volunteers. Bell EC; Willson MC; Wilman AH; Dave S; Silverstone PH Hum Psychopharmacol; 2005 Aug; 20(6):415-24. PubMed ID: 16106488 [TBL] [Abstract][Full Text] [Related]
16. Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat. Patsalos PN; Lascelles PT J Neurochem; 1981 Feb; 36(2):688-95. PubMed ID: 6109766 [TBL] [Abstract][Full Text] [Related]
17. Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice. Srivastava AK; Gupta YK Indian J Physiol Pharmacol; 2001 Oct; 45(4):475-80. PubMed ID: 11883156 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic lithium and sodium valproate on concentrations of brain amino acids. O'Donnell T; Rotzinger S; Ulrich M; Hanstock CC; Nakashima TT; Silverstone PH Eur Neuropsychopharmacol; 2003 Aug; 13(4):220-7. PubMed ID: 12888180 [TBL] [Abstract][Full Text] [Related]
19. Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice. Castro AA; Casagrande TS; Moretti M; Constantino L; Petronilho F; Guerra GC; Calo' G; Guerrini R; Dal-Pizzol F; Quevedo J; Gavioli EC Peptides; 2009 Oct; 30(10):1914-20. PubMed ID: 19616051 [TBL] [Abstract][Full Text] [Related]
20. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats. Sobaniec W; Sobaniec-Lotowska M Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]